Combination Chemotherapy of Mitomycin C and Methotrexate Was Effective on Metastatic Breast Cancer Resistant to Eribulin, Vinorelbine, and Bevacizumab after Anthracycline, Taxane, and Capecitabine

Complete cure of metastatic breast cancer (MBC) is still considered difficult even after the development of new drugs. While new drugs have been continuously developed, conventional drugs such as mitomycin C (MMC) and methotrexate (MTX) have become less used. Combination chemotherapy with MMC and MT...

Descripción completa

Detalles Bibliográficos
Autor principal: Tanabe, Masahiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5043245/
https://www.ncbi.nlm.nih.gov/pubmed/27721762
http://dx.doi.org/10.1159/000447770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5043245/
https://www.ncbi.nlm.nih.gov/pubmed/27721762
http://dx.doi.org/10.1159/000447770

Ejemplares similares